EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lipid A in outer membrane vesicles shields bacteria from polymyxins

Marie Burt, Georgia Angelidou, Christopher Nils Mais, Christian Preußer, Timo Glatter, Thomas Heimerl, Rüdiger Groß, Javier Serrania, Gowtham Boosarpu, Elke Pogge von Strandmann, Janis A Müller iD, Gert Bange und 8 weitere

Journal of Extracellular Vesicles · 2024

DOI: 10.1002/jev2.12447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Marie Burt und 19 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lung Research, Universities of Giessen and Marburg Lung Center, German Center for Lung Research (DZL), Philipps-University Marburg, Mar…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Anti-Bacterial Agents, Polymyxin B. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hessisches Ministerium für Wissenschaft und Kunst, Deutsche Forschungsgemeinschaft, von Behring-Röntgen-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continuous emergence of multidrug‐resistant bacterial pathogens poses a major global healthcare challenge, with Klebsiella pneumoniae being a prominent threat. We conducted a comprehensive study on K. pneumoniae ’s antibiotic resistance mechanisms, focusing on outer membrane vesicles (OMVs) and polymyxin, a last‐resort antibiotic. Our research demonstrates that OMVs protect bacteria from polymyxins. OMVs derived from Polymyxin B (PB)‐stressed K. pneumoniae exhibited heightened protective efficacy due to increased vesiculation, compared to OMVs from unstressed Klebsiella . OMVs also shield bacteria from different bacterial families. This was validated ex vivo and in vivo using precision cut lung slices (PCLS) and Galleria mellonella . In all models, OMVs protected K. pneumoniae from PB and reduced the associated stress response on protein level. We observed significant changes in the lipid composition of OMVs upon PB treatment, affecting their binding capacity to PB. The altered binding capacity of single OMVs from PB stressed K. pneumoniae could be linked to a reduction in the lipid A amount of their released vesicles. Although the amount of lipid A per vesicle is reduced, the overall increase in the number of vesicles results in an increased protection because the sum of lipid A and therefore PB binding sites have increased. This unravels the mechanism of the altered PB protective efficacy of OMVs from PB stressed K. pneumoniae compared to control OMVs. The lipid A‐dependent protective effect against PB was confirmed in vitro using artificial vesicles. Moreover, artificial vesicles successfully protected Klebsiella from PB ex vivo and in vivo. The findings indicate that OMVs act as protective shields for bacteria by binding to polymyxins, effectively serving as decoys and preventing antibiotic interaction with the cell surface. Our findings provide valuable insights into the mechanisms underlying antibiotic cross‐protection and offer potential avenues for the development of novel therapeutic interventions to address the escalating threat of multidrug‐resistant bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAnti-Bacterial AgentsPolymyxin BAnimalsBacterial Outer MembranePolymyxinsExtracellular VesiclesKlebsiella InfectionsMicrobial Sensitivity TestsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

antimicrobial peptides (AMP)bacterial extracellular vesiclesbacterial resistance mechanismslast‐resort antibioticlipid Amulti‐drug resistance (MDR)polymyxins

Substanzen

Anti-Bacterial AgentsPolymyxin BPolymyxins

Autor:innen und Institutionen

  • Institute for Lung Research, Universities of Giessen and Marburg Lung Center, German Center for Lung Research (DZL), Philipps-University Marburg, Marburg, Germany.
  • Core Facility for Metabolomics and Small Molecules Mass Spectrometry, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
  • Core Facility for Mass Spectrometry and Proteomics, Max Planck Institute for terrestrial Microbiology, Marburg, Germany.
  • Center for Synthetic Microbiology (SYNMIKRO), Philipps-University Marburg, Marburg, Germany.
  • Institute for Tumor Immunology, Philipps-University Marburg, Marburg, Germany.
  • Core Facility - Extracellular Vesicles, Philipps-University Marburg, Marburg, Germany.

ORCID-Profile: Janis A Müller, Anna Lena Jung

Förderung

  • Hessisches Ministerium für Wissenschaft und Kunst
  • Deutsche Forschungsgemeinschaft
  • von Behring-Röntgen-Stiftung
  • German Center for Lung Research (DZL)
  • German Ministry for Education and Research (BMBF)

Zitieren

APA

Burt, M., Angelidou, G., Mais, C. N., Preußer, C., Glatter, T., Heimerl, T., Groß, R., Serrania, J., Boosarpu, G., Pogge von Strandmann, E., Müller, J. A., Bange, G., Becker, A., Lehmann, M., Jonigk, D., Neubert, L., Freitag, H., Paczia, N., Schmeck, B., & Jung, A. L. (2024). Lipid A in outer membrane vesicles shields bacteria from polymyxins. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12447

Vancouver

Burt M, Angelidou G, Mais CN, Preußer C, Glatter T, Heimerl T, et al. Lipid A in outer membrane vesicles shields bacteria from polymyxins. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12447

BibTeX
@article{Burt2024,
  author = {Burt, Marie and Angelidou, Georgia and Mais, Christopher Nils and Preußer, Christian and Glatter, Timo and Heimerl, Thomas and Groß, Rüdiger and Serrania, Javier and Boosarpu, Gowtham and Pogge von Strandmann, Elke and Müller, Janis A and Bange, Gert and Becker, Anke and Lehmann, Mareike and Jonigk, Danny and Neubert, Lavinia and Freitag, Hinrich and Paczia, Nicole and Schmeck, Bernd and Jung, Anna Lena},
  title = {Lipid A in outer membrane vesicles shields bacteria from polymyxins},
  journal = {Journal of Extracellular Vesicles},
  year = {2024},
  doi = {10.1002/jev2.12447}
}
Kostenlos starten →